Código QR (código de barras bidimensional)

MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis

BackgroundGlioma, an aggressive brain tumor, poses a challenge in understanding the mechanisms of treatment resistance, despite promising results from immunotherapy.MethodsGenes associated with immunotherapy resistance were identified by analyzing The Cancer Genome Atlas (TCGA), the Chinese Glioma G...

תיאור מלא

שמור ב:
Principais autores: Yuanhao Lv, Ying Gao, Wenyu Di, Zhaoyi Li, Yashen Shi, Tianyuan Hou, Yiyang Chen, Jiaqi Tian, Miaoming Xu, Wei Su, Min Zhang, Jiateng Zhong
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2025-02-01
סדרה:Frontiers in Pharmacology
נושאים:
MFAP4
prognosis
biomarker
immunotherapy
gliomas
ferroptosis
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fphar.2025.1551863/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים